Additionally, our single‐center ancestry‐genotypic frequencies for UGT1A1 in sacituzumab recipients with breast cancer align with past studies that investigated the prevalence of UGT1A1*28 across races and ethnicities.16, 17, 18. This evidence concerns the gene UGT1A1 and breast carcinoma.